A Scoring System for Predicting Microvascular Invasion in Hepatocellular Carcinoma Based on Quantitative Functional MRI
Authors:
- Chien-Chang LiaoCLChien-Chang Liao
- Yu-Fan ChengYCYu-Fan Cheng
- Chun-Yen YuCYChun-Yen Yu
- Leung-Chit Leo TsangLTLeung-Chit Leo Tsang
- Chao-Long ChenCCChao-Long Chen
- Hsien-Wen HsuHHHsien-Wen Hsu
- Wan-Ching ChangWCWan-Ching Chang
- Wei-Xiong LimWLWei-Xiong Lim
- Yi-Hsuan ChuangYCYi-Hsuan Chuang
- Po-Hsun HuangPHPo-Hsun Huang
- Hsin-You OuHOHsin-You Ou
Open Access
- 30 June 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3789
Abstract
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is a histopathological marker and risk factor for HCC recurrence. We integrated diffusion-weighted imaging (DWI) and magnetic resonance (MR) image findings of tumors into a scoring system for predicting MVI. In total, 228 HCC patients with pathologically confirmed MVI who underwent surgical resection or liver transplant between November 2012 and March 2021 were enrolled retrospectively. Patients were divided into a right liver lobe group (n = 173, 75.9%) as the model dataset and a left liver lobe group (n = 55, 24.1%) as the model validation dataset. Multivariate logistic regression identified two-segment involved tumor (Score: 1; OR: 3.14; 95% CI: 1.22 to 8.06; p = 0.017); ADCmin ≤ 0.95 × 10−3 mm2/s (Score: 2; OR: 10.88; 95% CI: 4.61 to 25.68; p = 0.000); and largest single tumor diameter ≥ 3 cm (Score: 1; OR: 5.05; 95% CI: 2.25 to 11.30; p = 0.000), as predictive factors for the scoring model. Among all patients, sensitivity was 89.66%, specificity 58.04%, positive predictive value 68.87%, and negative predictive value 84.41%. For validation of left lobe group, sensitivity was 80.64%, specificity 70.83%, positive predictive value 78.12%, and negative predictive value 73.91%. The scoring model using ADCmin, largest tumor diameter, and two-segment involved tumor provides high sensitivity and negative predictive value in MVI prediction for use in routine functional MR.Keywords
Funding Information
- Ministry of Science and Technology, R.O.C. (NMRPG8K0031 (MOST 109-2314-B-182A-046), NMRPG8L0121 (MOST 110-2314-B-182A-061))
This publication has 56 references indexed in Scilit:
- Microvascular invasion in small hepatocellular carcinoma: Is it predictable with preoperative diffusion‐weighted imaging?Journal of Gastroenterology and Hepatology, 2014
- A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic VariabilityAnnals of Surgical Oncology, 2012
- Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan CriteriaAnnals of Surgery, 2011
- Influence of cardiac motion on diffusion-weighted magnetic resonance imaging of the liverMagnetic Resonance Materials in Physics, Biology and Medicine, 2009
- Recurrence of Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle BiopsyAnnals of Surgery, 2007
- Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomesSurgery, 2007
- Presentation of multivariate data for clinical use: The Framingham Study risk score functionsStatistics in Medicine, 2004
- Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedureJournal of the American College of Surgeons, 1999